|
Volumn 217, Issue 9, 2000, Pages 1366-1371
|
Cardiorespiratory effects of four α2-adrenoceptor agonist-ketamine combinations in captive red wolves
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACEPROMAZINE;
ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
BUTORPHANOL;
KETAMINE;
MEDETOMIDINE;
XYLAZINE;
ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT;
ANESTHETIC AGENT;
NARCOTIC ANALGESIC AGENT;
ANESTHESIA;
ANIMAL EXPERIMENT;
ARTICLE;
CARDIOPULMONARY HEMODYNAMICS;
CONTROLLED STUDY;
DRUG EFFECT;
FEMALE;
HYPERTENSION;
MALE;
NONHUMAN;
PATHOGENESIS;
RISK ASSESSMENT;
WOLF;
ANIMAL;
ANIMAL DISEASE;
BLOOD GAS ANALYSIS;
BLOOD PRESSURE;
BODY TEMPERATURE;
BREATHING;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
ELECTROCARDIOGRAPHY;
ENVIRONMENTAL PROTECTION;
HEART RATE;
OXIMETRY;
PHYSIOLOGY;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
ANIMALIA;
CANIDAE;
CANIS;
CANIS RUFUS;
ACEPROMAZINE;
ADRENERGIC ALPHA-AGONISTS;
ANALGESICS, OPIOID;
ANESTHETICS, DISSOCIATIVE;
ANIMALS;
BLOOD GAS ANALYSIS;
BLOOD PRESSURE;
BODY TEMPERATURE;
BUTORPHANOL;
CONSERVATION OF NATURAL RESOURCES;
ELECTROCARDIOGRAPHY;
FEMALE;
HEART RATE;
KETAMINE;
MALE;
MEDETOMIDINE;
OXIMETRY;
PROSPECTIVE STUDIES;
RESPIRATION;
WOLVES;
XYLAZINE;
|
EID: 0034310718
PISSN: 00031488
EISSN: None
Source Type: Journal
DOI: 10.2460/javma.2000.217.1366 Document Type: Article |
Times cited : (32)
|
References (39)
|